News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,061 Results
Type
Article (13863)
Company Profile (293)
Press Release (244905)
Section
Business (79326)
Career Advice (150)
Deals (13180)
Drug Delivery (31)
Drug Development (50268)
Employer Resources (31)
FDA (5672)
Job Trends (5111)
News (144061)
Policy (10019)
Tag
Academia (905)
Alliances (21447)
Alzheimer's disease (732)
Approvals (5635)
Artificial intelligence (59)
Bankruptcy (97)
Best Places to Work (4457)
Biotechnology (241)
Breast cancer (57)
Cancer (574)
Cardiovascular disease (52)
Career advice (131)
CAR-T (44)
Cell therapy (149)
Clinical research (39584)
Collaboration (202)
Compensation (83)
COVID-19 (1000)
C-suite (53)
Cystic fibrosis (61)
Data (612)
Diabetes (64)
Diagnostics (1191)
Earnings (28581)
Events (46519)
Executive appointments (154)
FDA (5915)
Funding (207)
Gene editing (48)
Gene therapy (127)
GLP-1 (290)
Government (1065)
Healthcare (6529)
Infectious disease (1029)
Inflammatory bowel disease (89)
IPO (7168)
Job creations (862)
Job search strategy (126)
Layoffs (181)
Legal (1373)
Lung cancer (101)
Manufacturing (66)
Medical device (2548)
Medtech (2549)
Mergers & acquisitions (6091)
Metabolic disorders (203)
Neuroscience (912)
NextGen Class of 2024 (1998)
Non-profit (845)
Northern California (783)
Obesity (117)
Opinion (91)
Parkinson's disease (55)
Patents (45)
People (24900)
Pharmaceutical (48)
Phase I (13911)
Phase II (18405)
Phase III (11683)
Pipeline (139)
Postmarket research (846)
Preclinical (5872)
Radiopharmaceuticals (203)
Rare diseases (140)
Real estate (1411)
Regulatory (8162)
Research institute (931)
Southern California (725)
Startups (1963)
United States (6586)
Vaccines (154)
Weight loss (74)
Date
Today (146)
Last 7 days (517)
Last 30 days (1828)
Last 365 days (20682)
2024 (17692)
2023 (22415)
2022 (26826)
2021 (27810)
2020 (23362)
2019 (16233)
2018 (11748)
2017 (13747)
2016 (11848)
2015 (14357)
2014 (10400)
2013 (7492)
2012 (7542)
2011 (7618)
2010 (7432)
Location
Africa (147)
Asia (16772)
Australia (2821)
California (1777)
Canada (645)
China (134)
Colorado (65)
Connecticut (71)
Europe (36086)
Florida (191)
Georgia (51)
Illinois (111)
Indiana (51)
Kansas (54)
Maryland (261)
Massachusetts (1479)
Michigan (45)
Minnesota (82)
New Jersey (482)
New York (541)
North Carolina (381)
Northern California (783)
Ohio (72)
Pennsylvania (374)
South America (208)
Southern California (725)
Texas (181)
Washington State (197)
259,061 Results for "wren therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Wren Laboratories Unveils Dynamic Executive Leadership Team and 2024 Commercial Strategy Overhaul
Wren Laboratories, a leader in novel in-vitro diagnostic technologies, announced significant enhancements to its executive leadership team.
June 17, 2024
·
5 min read
Genetown
Wren Therapeutics Renamed WaveBreak, Signifying Focus on Stopping the Wave of Neurodegeneration in Parkinson’s Disease, Alzheimer’s Disease, and ALS at its Source
Wren Therapeutics announced today that the company has changed its name to WaveBreak.
April 25, 2023
·
2 min read
Genetown
Wren Builds Out Scientific Advisory Board for Neurodegenerative Diseases
Wren Therapeutics announced a number of new members to its Scientific Advisory Board.
January 4, 2023
·
3 min read
Wren Laboratories Dr. Mark Kidd to speak at 2024 Precision Medicine World Conference
The presentation will focus on the use of mRNA in Liquid Biopsies as a platform for precision diagnostics
January 19, 2024
·
1 min read
Genetown
Wren Presents Preclinical Data at AD/PD 2023 Demonstrating Potential of its First-in-Class, Small-Molecule Inhibitors of α-Synuclein Toxic Oligomers for the Treatment of Parkinson’s Disease
Wren announced today the presentation of preclinical data for its first-in-class, oral inhibitors of α-synuclein oligomer generation demonstrating potent inhibition of both oligomer production and aggregate formation in cell and mouse models used for studying Parkinson’s disease progression.
March 29, 2023
·
6 min read
Business
Wren Taps Vertex Veteran Executives and Other Leaders to Advance First-in-Class Small-Molecule Drugs into Clinical Testing for Neurodegenerative Diseases
Wren Therapeutics announced today a number of senior leadership appointments as the company advances its first investigational therapies toward the clinic, based on the company’s breakthrough approach to discovering small molecules that precisely target and shut down the sources of oligomer and aggregate generation in neurodegenerative diseases.
December 8, 2022
·
5 min read
Business
Wren Appoints Bart Henderson as Chief Executive Officer
Wren Therapeutics, a biopharmaceutical company transforming drug discovery for neurodegenerative diseases, announced the appointment of Bart Henderson as Chief Executive Officer.
March 4, 2022
·
2 min read
Wren Laboratories’ new molecular diagnostic predicts patient response to Peptide Receptor Radionuclide Therapy with unprecedented accuracy
Neuroendocrine Cancer treatment response test, PPQ, delivers 96% accuracy
September 25, 2023
·
2 min read
Wren Laboratories’ NETest leverages mRNA and Artificial Intelligence to create highly accurate, personalized neuroendocrine cancer diagnostics
With NETest, oncologists at leading cancer centers around the globe have a highly accurate molecular diagnostic to add to their patient care arsenal.
August 11, 2023
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 25,907
Next